312 related articles for article (PubMed ID: 26423473)
21. Pediatric Pituitary Adenomas: Early and Long-Term Surgical Outcome in a Series of 85 Consecutive Patients.
Barzaghi LR; Losa M; Capitanio JF; Albano L; Weber G; Mortini P
Neurosurgery; 2019 Jul; 85(1):65-74. PubMed ID: 29790934
[TBL] [Abstract][Full Text] [Related]
22. Iran Pituitary Tumor Registry: Description of the Program and Initial Results.
Khamseh ME; Mohajeri Tehrani MR; Mousavi Z; Malek M; Imani M; Hoshangian Tehrani N; Ghorbani M; Akbari H; Sarvghadi F; Amouzegar A; Esfahanian F; Hashemi Madani N; Emami Z
Arch Iran Med; 2017 Dec; 20(12):746-751. PubMed ID: 29664314
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.
Larouche V; Correa JA; Cassidy P; Beauregard C; Garfield N; Rivera J
Pituitary; 2016 Apr; 19(2):202-9. PubMed ID: 26700946
[TBL] [Abstract][Full Text] [Related]
24. Clinical and epidemiological characteristics of pituitary tumours in a single centre in Saudi Arabia.
Hussein SH; Wahedi TS; Johani NA; Hakami YA; Alzahrani K; AlMalki MH
Hormones (Athens); 2018 Jun; 17(2):261-267. PubMed ID: 29858852
[TBL] [Abstract][Full Text] [Related]
25. Clinical and endocrine aspects of pituitary tumors.
Zargar AH; Laway BA; Masoodi SR; Salahuddin M; Ganie MA; Bhat MH; Wani AI; Bashir MI
Saudi Med J; 2004 Oct; 25(10):1428-32. PubMed ID: 15494816
[TBL] [Abstract][Full Text] [Related]
26. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
27. Pituitary tumors in adolescent patients.
Artese R; D'Osvaldo DH; Molocznik I; Benencia H; Oviedo J; Burdman JA; Basso A
Neurol Res; 1998 Jul; 20(5):415-417. PubMed ID: 9664587
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study.
Gruppetta M; Vassallo J
Clin Endocrinol (Oxf); 2016 Aug; 85(2):223-31. PubMed ID: 26998693
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiology of pituitary adenoma: results of the first Swiss study].
Fontana E; Gaillard R
Rev Med Suisse; 2009 Oct; 5(223):2172-4. PubMed ID: 19968031
[TBL] [Abstract][Full Text] [Related]
30. Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal.
Tortosa F; Webb SM
Neurologia; 2016 Mar; 31(2):97-105. PubMed ID: 26300499
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
32. Multiple pituitary adenomas in Cushing's disease.
Ratliff JK; Oldfield EH
J Neurosurg; 2000 Nov; 93(5):753-61. PubMed ID: 11059654
[TBL] [Abstract][Full Text] [Related]
33. Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas.
Ozkaya HM; Sahin S; Korkmaz OP; Durcan E; Sahin HR; Celik E; Poyraz BC; Kadioglu P
Growth Horm IGF Res; 2020 Dec; 55():101356. PubMed ID: 33010581
[TBL] [Abstract][Full Text] [Related]
34. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
[TBL] [Abstract][Full Text] [Related]
35. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls.
Sievers C; Ising M; Pfister H; Dimopoulou C; Schneider HJ; Roemmler J; Schopohl J; Stalla GK
Eur J Endocrinol; 2009 Mar; 160(3):367-73. PubMed ID: 19073833
[TBL] [Abstract][Full Text] [Related]
36. The risks of overlooking the diagnosis of secreting pituitary adenomas.
Brue T; Castinetti F
Orphanet J Rare Dis; 2016 Oct; 11(1):135. PubMed ID: 27716353
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of pituitary adenomas in a community-based hospital: a retrospective single center study in Saudi Arabia.
Aljabri KS; Bokhari SA; Assiri FY; Alshareef MA; Khan PM
Ann Saudi Med; 2016; 36(5):341-345. PubMed ID: 27710986
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Functioning Pituitary Adenomas.
Chin SO
Endocrinol Metab (Seoul); 2020 Jun; 35(2):237-242. PubMed ID: 32615708
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.
Ntali G; Wass JA
Pituitary; 2018 Apr; 21(2):111-118. PubMed ID: 29368293
[TBL] [Abstract][Full Text] [Related]
40. Sellar Masses: An Epidemiological Study.
Al-Dahmani K; Mohammad S; Imran F; Theriault C; Doucette S; Zwicker D; Yip CE; Clarke DB; Imran SA
Can J Neurol Sci; 2016 Mar; 43(2):291-7. PubMed ID: 26522017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
